← Back to Clinical Trials
Recruiting NCT04962295

China Imaging-based Biobank of Cerebral Small Vessal Diseases

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Cerebral Small Vessel Diseases
Sponsor Peking University Third Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2020-10-01
Completion 2025-12-31
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to build a national image-based comprehensive evaluation platform of CSVD through longitudinal collection of imaging based medical data of patients with cerebral small vessel diseases (CSVD). On this basis, the new classification and diagnostic criteria of CSVD are proposed, and the risk prediction model of CSVD is established. By evaluating the prognostic factors of CSVD, early identification of high-risk CSVD population.

Eligibility Criteria

Inclusion Criteria: 1. Age ≥ 18 years old 2. SVD lesions can be seen on MRI of the head * White matter hyperintensity, Fazekas score ≥ 2 * Fazekas=1 has more than 2 vascular risk factors (hypertension, hyperlipidemia, diabetes, obesity, smoking, and other vascular events except stroke). * Fazekas = 1 and combined with lacunar focus * Imaging findings suggest new subcortical lacunar infarction 3. Daily life independence (MRS ≤ 2) 4. Sign informed consent Note: the imaging definition of small vessel disease refers to the strong guideline 1. The total score of Fazekas was 6, which was the sum of Fazekas scores of subcortical and periventricular white matter lesions. 2. New subcortical lacunar infarction: head MRI examination, subcortical, basal ganglia or brain stem DWI showed high signal (ADC diffusion limited) lesions with diameter \< 20 mm, with or without corresponding clinical symptoms; There were new clinical symptoms. FLAIR sequence of head MRI showed flair hyperintense lesions (di

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}